Return to homepagePandemic Pact

CYTOF AND O-LINK ASSESSMENT IN THE `NCI COVID-19 IN CANCER PATIENTS STUDY' (NCCAPS)

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N91021C00003-0-9999-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $2,712,342

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    SACHA GNJATIC

  • Research Location

    United States of America

  • Lead Research Institution

    ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Individuals with multimorbidity, Other

  • Occupations of Interest

    Unspecified

Abstract

The primary objective of this project is to study the immune response to COVID-19 in patients with cancer by assessing the cellular compartment of the immune system using mass cytometry by CyTOF and cytokines by O-link profiling.